M&A Europe: Back to deal-making & value creation
Banking | Pharmaceuticals | industry | Brics | IP
Divestments, cross-border consolidation, emerging markets : state -of-the art practices serving winning strategies
Mergers and acquisitions activity in Europe awakes from a long slumber.
The global M&A market ended two years of malaise in 2010, rebounding decisively in the second half of last year.
The dollar volume of takeover deals with a European target was $192.3 billion for the first quarter of 2011, up to 10% compared with the first quarter of last year, but down 17% from the fourth quarter according to research firm Dealogic.
Having spent a good part of the time since the financial crisis erupted strengthening their finances, companies have today the desire and wherewithal to do M&A deals again. Companies announced more than 7,000 deals, at a value of $2.7 trillion in 2010, which is the first increase since 2007. The trend in M&A includes continued growth in cross-border M&A, an increase in the number of deals in Asia and Latin America, and modest growth in private-equity deal volumes.
The number of mergers and acquisitions is expected to rise over the next few years, therefore many companies are looking for ways to improve their M&A skills —especially their ability to assess and integrate target companies successfully.
This major continental initiative organized around two roundtables in the morning and four workshops in the afternoon on specific areas namely :
Pharma & Biotech Industry,
Emerging markets, ....
will be framed by an introductory session with Mr Karel De Gught, European Commissioner for Trade.
In order to receive the programme when released, please e-mail [email protected]
Information & registration
Partenaires : CMS, Finnegan, Dealogic